PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Jan-2025 PRODUCTLIFE GROUP ACQUIRES STRAGEN SERVICES, STRENGTHENING PHARMACOVIGILANCE AND CLINICAL SAFETY EXPERTISE WITHIN THE EUROPEAN MARKET ProductLife Group (PLG)
28-Jan-2025 Clinigen Announces Strategic Partnership with Tepsivo Clinigen
28-Jan-2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency GSK
28-Jan-2025 Legal & General completes £1.4 billion buy-in with the Sanofi Pension Scheme Legal & General
28-Jan-2025 ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research ENA Respiratory
28-Jan-2025 Commit Biologics announces €5.5m seed financing extension investment by Korys to further develop its Bispecific Complement Engaging (BiCE™) platform Commit Biologics
28-Jan-2025 OncoZenge enters into SEK 30.2 million investment agreement with new strategic investor Sichuan Yangtian Bio-Pharmaceutical, intended to be carried out through directed share issues OncoZenge
28-Jan-2025 FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL) Merck
28-Jan-2025 Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer Roche
28-Jan-2025 Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD) Roche
28-Jan-2025 Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP GSK
28-Jan-2025 Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP GSK
28-Jan-2025 Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies AstraZeneca
28-Jan-2025 Abivax Publishes 2025 Financial Calendar ABIVAX
28-Jan-2025 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 Sartorius Stedim Biotech SA
27-Jan-2025 Eckert & Ziegler Announces Preliminary Figures for 2024: Significant Increase in Sales and Adjusted EBIT Eckert & Ziegler SE
27-Jan-2025 Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters Straumann Holding AG
27-Jan-2025 Invitation to Straumann Group’s 2024 full-year results webcast Straumann Holding AG
27-Jan-2025 CapeStart Closes 2024 with New Clients, Strategic Hires and Launch of MadeAi CapeStart
27-Jan-2025 Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements Mainz BioMed N.V.